Charles Schwab’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.28M Buy
113,496
+372
+0.3% +$4.21K ﹤0.01% 2822
2025
Q1
$1.31M Buy
113,124
+12,776
+13% +$147K ﹤0.01% 2753
2024
Q4
$850K Sell
100,348
-10,372
-9% -$87.9K ﹤0.01% 2966
2024
Q3
$1.28M Buy
110,720
+126
+0.1% +$1.46K ﹤0.01% 2842
2024
Q2
$1.3M Buy
110,594
+32,456
+42% +$382K ﹤0.01% 2837
2024
Q1
$927K Sell
78,138
-2,313
-3% -$27.4K ﹤0.01% 2815
2023
Q4
$986K Buy
80,451
+15,297
+23% +$187K ﹤0.01% 2837
2023
Q3
$627K Hold
65,154
﹤0.01% 2961
2023
Q2
$586K Buy
65,154
+1,287
+2% +$11.6K ﹤0.01% 2972
2023
Q1
$502K Buy
63,867
+751
+1% +$5.9K ﹤0.01% 2947
2022
Q4
$427K Hold
63,116
﹤0.01% 3041
2022
Q3
$916K Buy
63,116
+217
+0.3% +$3.15K ﹤0.01% 2814
2022
Q2
$619K Buy
62,899
+4,484
+8% +$44.1K ﹤0.01% 2984
2022
Q1
$862K Buy
58,415
+1,000
+2% +$14.8K ﹤0.01% 2907
2021
Q4
$760K Buy
57,415
+5,317
+10% +$70.4K ﹤0.01% 3015
2021
Q3
$910K Buy
52,098
+3,937
+8% +$68.8K ﹤0.01% 2906
2021
Q2
$1.15M Buy
48,161
+1,264
+3% +$30.3K ﹤0.01% 2876
2021
Q1
$1.21M Buy
46,897
+13,310
+40% +$342K ﹤0.01% 2792
2020
Q4
$638K Buy
33,587
+2,597
+8% +$49.3K ﹤0.01% 2909
2020
Q3
$391K Sell
30,990
-1,431
-4% -$18.1K ﹤0.01% 2953
2020
Q2
$393K Buy
32,421
+2,592
+9% +$31.4K ﹤0.01% 2922
2020
Q1
$229K Hold
29,829
﹤0.01% 2978
2019
Q4
$532K Buy
29,829
+2,536
+9% +$45.2K ﹤0.01% 2798
2019
Q3
$317K Hold
27,293
﹤0.01% 2955
2019
Q2
$605K Buy
+27,293
New +$605K ﹤0.01% 2734
2016
Q2
Sell
-1,125
Closed -$11K 3123
2016
Q1
$11K Hold
1,125
﹤0.01% 3051
2015
Q4
$58K Hold
1,125
﹤0.01% 3065
2015
Q3
$57K Hold
1,125
﹤0.01% 3063
2015
Q2
$113K Buy
+1,125
New +$113K ﹤0.01% 3041